Author’s Reply to Correspondence: “Effect of Tolvaptan Treatment on Acid−Base Homeostasis in ADPKD Patients” by Judith E. Heida, Ron T. Gansevoort, Esther Meijer

Get full text

Effectivity of (Personalized) Cognitive Behavioral Therapy for Insomnia in Mental Health Populations and the Elderly: An Overview by Teus Mijnster, Gretha J. Boersma, Esther Meijer, Marike Lancel

Get full text

Association of plasma somatostatin with disease severity and progression in patients with autosomal dominant polycystic kidney disease by A. Lianne Messchendorp, Edwin M. Spithoven, Niek F. Casteleijn, Wendy A. Dam, Jacob van den Born, Wouter F. Tonnis, Carlo A. J. M. Gaillard, Esther Meijer, on behalf of the DIPAK Consortium

Get full text

Urinary Biomarkers to Identify Autosomal Dominant Polycystic Kidney Disease Patients With a High Likelihood of Disease Progression by A. Lianne Messchendorp, Esther Meijer, Wendy E. Boertien, Gerwin E. Engels, Niek F. Casteleijn, Edwin M. Spithoven, Monique Losekoot, Johannes G.M. Burgerhof, Dorien J.M. Peters, Ron T. Gansevoort

Get full text

Urinary Tissue Inhibitor of Metalloproteinases-2 and Insulin-Like Growth Factor–Binding Protein 7 Do Not Correlate With Disease Severity in ADPKD Patients by Shosha E.I. Dekker, L. Renee Ruhaak, Fred P.H.T.M. Romijn, Esther Meijer, Christa M. Cobbaert, Johan W. de Fijter, Darius Soonawala, Joost P.H. Drenth, Johan W. de Fijter, Ron T. Gansevoort, Dorien J.M. Peters, Jack F. Wetzels, Robert Zietse

Get full text

HYDROchlorothiazide versus placebo to PROTECT polycystic kidney disease patients and improve their quality of life: study protocol and rationale for the HYDRO-PROTECT randomized co... by Thomas Bais, Esther Meijer, Bart J. Kramers, Priya Vart, Marc Vervloet, Mahdi Salih, Bert Bammens, Nathalie Demoulin, Polina Todorova, Roman-Ulrich Müller, Jan Halbritter, Alexander Paliege, Emilie Cornec-Le Gall, Bertrand Knebelmann, Roser Torra, Albert C. M. Ong, Fiona E. Karet Frankl, Ron T. Gansevoort

Get full text